The 1 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 36.00, with a high estimate of 36.00 and a low estimate of 36.00. The median estimate represents a +9.32% increase from the last price of 32.93.
The current consensus among 1 polled investment analysts is to Hold stock in Natus Medical Inc. This rating has held steady since January, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.32
Reporting Date Jul 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.